An Alzheimer’s drug did not have an effect on cognitive function in breast cancer survivors. However, one researcher noted reasons why there is still hope. Although Aricept (donepezil), a ...
The patent wall protecting Eisai‘s (TYO:4523) blockbuster Alzheimer’s disease drug Aricept is crumbling fast with two more generics companies receiving U.S. Food and Drug Administration approval this ...
(CBS/AP) Alzheimer's disease patients who are taking a commonly prescribed drug can still benefit from it after they progress to moderate-to-severe illness, when it can be tough to tell whether it's ...
GENEVA, SWITZERLAND (4 APRIL 2002) - Results from the first head-to-head study comparing ARICEPT® (donepezil HCl tablets) and Reminyl® (galantamine HBr tablets) demonstrated significantly greater ...
Eisai got an FDA untitled letter for two Aricept TV ads that the agency said overstate the efficacy of the drug. The ads, “Beach” and “Garden,” feature women recounting seeing the signs of advancing ...
Watching Alzheimer’s disease steal away the memory, talents and very selves of its victims is hard enough for the people who love them. Now, a new pill formulated by a respected pharmaceutical company ...
Alzheimer’s disease patients who are taking a commonly prescribed drug can still benefit from it after they progress to moderate-to-severe illness, when it can be tough to tell whether it’s doing any ...
Salzburg, Austria - Treatment with ARICEPT® (donepezil hydrochloride tablets) significantly improved the cognitive and global (overall) function of patients with vascular dementia (VaD), compared with ...
Donepezil, marketed under the brand name Aricept, is an oral tablet medication prescribed for people living with Alzheimer’s disease. Medicare drug plans may cover the brand drug Aricept or its ...
March 17, 2006 — -- Doctors were not surprised to hear the news that 11 people in a clinical trial died while taking Aricept, a drug currently approved for use for patients with Alzheimer's ...
Generics maker Teva Pharmaceuticals USA Inc. has agreed to suspend litigation over a compound patent for Eisai Co. Ltd.'s popular Alzheimer's drug Aricept, effectively ending Teva's bid to manufacture ...
Dear Dr. Roach: I have a friend, age 56, who was diagnosed with Alzheimer’s disease a few years ago and has been taking Aricept, which has helped immensely. Now she has begun taking medical marijuana, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results